Spindle Shaped Human Mesenchymal Stem/Stromal Cells from Amniotic Fluid Promote Neovascularization

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Roubelakis, Maria G ^a,b   Tsaknakis, Grigorios ^b,c   Pappa, Kalliopi I ^a   Anagnou, Nicholas P ^a   Watt, Suzanne M ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Institute of Molecular Oncology   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; PROTEOME;

AMNIOTIC FLUID CELL; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; EMBRYONIC STEM CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PROTEIN FUNCTION; SKIN FIBROBLAST; SPINDLE CELL; TISSUE REPAIR; UMBILICAL CORD BLOOD;

AMNIOTIC FLUID; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC;

MURINAE; MUS;

EID: 84872841152     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054747     Document Type: Article

References (70)

1. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV, (1974) Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17: 331-340.
2. Caplan AI, (1991) Mesenchymal stem cells. J Orthop Res 9: 641-650.
3. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
4. Dexter TM, Allen TD, Lajtha LG, (1977) Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 91: 335-344.
5. English K, French A, Wood KJ, (2011) Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell 7: 431-442.
6. Pontikoglou C, Deschaseaux F, Sensebe L, Papadaki HA, (2011) Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev 7: 569-589.
7. Prockop DJ, Oh JY, (2012) Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther 20: 14-20.
8. Keating A, (2012) Mesenchymal stromal cells: new directions. Cell Stem Cell 10: 709-716.
9. Marigo I, Dazzi F, (2011) The immunomodulatory properties of mesenchymal stem cells. Semin Immunopathol 33: 593-602.
10. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.
11. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, et al. (2003) Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102: 1548-1549.
12. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, et al. (2004) Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22: 1330-1337.
13. Erices A, Conget P, Minguell JJ, (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109: 235-242.
14. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S, (2000) Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A 97: 13625-13630.
15. Shih DT, Lee DC, Chen SC, Tsai RY, Huang CT, et al. (2005) Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells 23: 1012-1020.
16. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE, (2005) Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23: 220-229.
17. Martin-Rendon E, Sweeney D, Lu F, Girdlestone J, Navarrete C, et al. (2008) 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang 95: 137-148.
18. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
19. Campagnoli C, Bellantuono I, Kumar S, Fairbairn LJ, Roberts I, et al. (2002) High transduction efficiency of circulating first trimester fetal mesenchymal stem cells: potential targets for in utero ex vivo gene therapy. BJOG 109: 952-954.
20. Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschlager M, (2003) Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod 18: 1489-1493.
21. Guillot PV, Gotherstrom C, Chan J, Kurata H, Fisk NM, (2007) Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25: 646-654.
22. Chan J, Kumar S, Fisk NM, (2008) First trimester embryo-fetoscopic and ultrasound-guided fetal blood sampling for ex vivo viral transduction of cultured human fetal mesenchymal stem cells. Hum Reprod 23: 2427-2437.
23. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, et al. (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25: 100-106.
24. Da Sacco S, Sedrakyan S, Boldrin F, Giuliani S, Parnigotto P, et al. (2010) Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J Urol 183: 1193-1200.
25. Abdulrazzak H, Moschidou D, Jones G, Guillot PV, (2010) Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J R Soc Interface 7Suppl 6: S689-706.
26. Klemmt PA, Vafaizadeh V, Groner B, (2011) The potential of amniotic fluid stem cells for cellular therapy and tissue engineering. Expert Opin Biol Ther 11: 1297-1314.
27. Roubelakis MG, Trohatou O, Anagnou NP, (2012) Amniotic fluid and amniotic membrane stem cells: marker discovery. Stem Cells Int 2012: 107836.
28. Tsai MS, Lee JL, Chang YJ, Hwang SM, (2004) Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 19: 1450-1456.
29. Roubelakis MG, Bitsika V, Zagoura D, Trohatou O, Pappa KI, et al. (2011) In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. J Cell Mol Med 15: 1896-1913.
30. Roubelakis MG, Pappa KI, Bitsika V, Zagoura D, Vlahou A, et al. (2007) Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 16: 931-952.
31. Ben-David U, Mayshar Y, Benvenisty N, (2011) Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell 9: 97-102.
32. Li H, Fan X, Kovi RC, Jo Y, Moquin B, et al. (2007) Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res 67: 10889-10898.
33. Mishra PJ, Glod JW, Banerjee D, (2009) Mesenchymal stem cells: flip side of the coin. Cancer Res 69: 1255-1258.
34. Rodriguez R, Rubio R, Masip M, Catalina P, Nieto A, et al. (2009) Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells. Neoplasia 11: 397-407.
35. Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, et al. (2005) Spontaneous human adult stem cell transformation. Cancer Res 65: 3035-3039.
36. Sensebe L, Tarte K, Galipeau J, Krampera M, Martin I, et al. (2012) Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells. Cell Stem Cell 10: 9-10; author reply 10-11.
37. Bitsika V, Roubelakis M, Zagoura D, Trohatou O, Makridakis M, et al. (2012) Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer. Stem Cells Dev 21: 1097-1111.
38. Athanassopoulos A, Tsaknakis G, Newey SE, Harris AL, Kean J, et al. (2012) Microvessel networks in pre-formed in artificial clinical grade dermal substitutes in vitro using cells from haematopoietic tissues. Burns 38: 691-701.
39. Walker NG, Mistry AR, Smith LE, Eves PC, Tsaknakis G, et al. (2012) A chemically defined carrier for the delivery of human mesenchymal stem/stromal cells to skin wounds. Tissue Eng Part C Methods 18: 143-155.
40. Zhang Y, Fisher N, Newey SE, Smythe J, Tatton L, et al. (2009) The impact of proliferative potential of umbilical cord-derived endothelial progenitor cells and hypoxia on vascular tubule formation in vitro. Stem Cells Dev 18: 359-375.
41. Zhou B, Tsaknakis G, Coldwell KE, Khoo CP, Roubelakis MG, et al. (2012) A novel function for the haemopoietic supportive murine bone marrow MS-5 mesenchymal stromal cell line in promoting human vasculogenesis and angiogenesis. Br J Haematol 157: 299-311.
42. Khoo CP, Micklem K, Watt SM, (2011) A comparison of methods for quantifying angiogenesis in the matrigel assay in vitro. Tissue Eng Part C Methods 17: 895-906.
43. Coldwell KE, Lee SJ, Kean J, Khoo CP, Tsaknakis G, et al. (2011) Effects of obstetric factors and storage temperatures on the yield of endothelial colony forming cells from umbilical cord blood. Angiogenesis 14: 381-392.
44. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, et al. (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109: 1801-1809.
45. Zagoura DS, Roubelakis MG, Bitsika V, Trohatou O, Pappa KI, et al. (2012) Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. Gut 61: 894-906.
46. Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, et al. (2006) Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 108: 1067-1072.
47. Leschot NJ, Verjaal M, Treffers PE, (1985) Risks of midtrimester amniocentesis; assessment in 3000 pregnancies. Br J Obstet Gynaecol 92: 804-807.
48. Makridakis M, Roubelakis MG, Bitsika V, Dimuccio V, Samiotaki M, et al. (2010) Analysis of secreted proteins for the study of bladder cancer cell aggressiveness. J Proteome Res 9: 3243-3259.
49. Reinisch A, Hofmann NA, Obenauf AC, Kashofer K, Rohde E, et al. (2009) Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood 113: 6716-6725.
50. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D, (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111: 1287-1295.
51. Farace P, Galie M, Merigo F, Daducci A, Calderan L, et al. (2009) Inhibition of tyrosine kinase receptors by SU6668 promotes abnormal stromal development at the periphery of carcinomas. Br J Cancer 100: 1575-1580.
52. Laird AD, Christensen JG, Li G, Carver J, Smith K, et al. (2002) SU6668 inhibits Flk-1/KDR and PDGFRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice. FASEB J 16: 681-690.
53. Zhang J, Cao R, Zhang Y, Jia T, Cao Y, et al. (2009) Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability. FASEB J 23: 153-163.
54. Melero-Martin JM, De Obaldia ME, Kang SY, Khan ZA, Yuan L, et al. (2008) Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103: 194-202.
55. Traktuev DO, Prater DN, Merfeld-Clauss S, Sanjeevaiah AR, Saadatzadeh MR, et al. (2009) Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells. Circ Res 104: 1410-1420.
56. Watt SM, Athanassopoulos A, Harris AL, Tsaknakis G, (2010) Human endothelial stem/progenitor cells, angiogenic factors and vascular repair. J R Soc Interface 7Suppl 6: S731-751.
57. Roelen DL, van der Mast BJ, in't Anker PS, Kleijburg C, Eikmans M, et al. (2009) Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells. Hum Immunol 70: 16-23.
58. McDermott SP, Eppert K, Lechman ER, Doedens M, Dick JE, (2011) Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood 116: 193-200.
59. Diamanti P, Cox CV, Blair A, (2011) Comparison of childhood leukemia initiating cell populations in NOD/SCID and NSG mice. Leukemia 26: 376-380.
60. De Spiegelaere W, Cornillie P, Van den Broeck W, Plendl J, Bahramsoltani M, (2011) Angiopoietins differentially influence in vitro angiogenesis by endothelial cells of different origin. Clin Hemorheol Microcirc 48: 15-27.
61. Kachgal S, Putnam AJ, (2011) Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms. Angiogenesis 14: 47-59.
62. Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, et al. (2003) Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 17: 1835-1840.
63. Lozito TP, Tuan RS, (2011) Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol 226: 385-396.
64. Newman AC, Nakatsu MN, Chou W, Gershon PD, Hughes CC, (2011) The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. Mol Biol Cell 22: 3791-3800.
65. Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, et al. (2001) Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 33: 95-102.
66. Rissanen TT, Markkanen JE, Arve K, Rutanen J, Kettunen MI, et al. (2003) Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. Faseb J 17: 100-102.
67. Rundhaug JE, (2005) Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9: 267-285.
68. Singh S, Wu S, Varney M, Singh AP, Singh RK, (2011) CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation. Microvasc Res 82: 318-325.
69. Zhang D, Ouyang J, Wang N, Zhang Y, Bie J, (2010) Promotion of PDGF-induced endothelial cell migration by phosphorylated VASP depends on PKA anchoring via AKAP. Mol Cell Biochem 335: 1-11.
70. Sessarego N, Parodi A, Podesta M, Benvenuto F, Mogni M, et al. (2008) Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica 93: 339-346.